Clinical study to detect micrometastasis of gynecologic malignancies using intraoperative sentinel lymph node investigation system

Clinical study to detect micrometastasis of gynecologic malignancies using intraoperative sentinel lymph node investigation system - Clinical study on sentinel lymphnode in gynecologic malignancies

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007816

Enrollment

150

Registered

2012-05-01

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecologic malignancies (cervical cancer, endometrial cancer, and vulvar cancer)

Interventions

99mTc labeled phytic acid and patent-blue dye is injected around the lesion one day before surgery and just prior to operation, respectively. Intraoperatively, colored sentinel lymph nodes (SLN) are a

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: cervical cancer stage Ia-IIb vulvar cancer stage Ia-II endometrial cancer stage Ia-II

Exclusion criteria

Exclusion criteria: Those who cannot be afforeded to standard therapy

Design outcomes

Primary

Measure	Time frame
Histopathologic diagnosis of dissected lymph nodes, positive rate of sentinel lymph nodes, and validity of dissection range	—

Countries

Japan

Contacts

Public ContactTsukasa Baba

Kyoto University Graduate School of Medicine Gynecology and Obstetrics

babatsu@kuhp.kyoto-u.ac.jp0757513269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026